Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46.4M
-
Number of holders
-
280
-
Total 13F shares, excl. options
-
44.7M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$547M
-
Value change
-
+$14.2M
-
Number of buys
-
129
-
Number of sells
-
-95
-
Price
-
$12.24
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q2 2025
313 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q2 2025.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 280 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.7M shares
of 46.4M outstanding shares and own 96.4% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.83M shares), VANGUARD GROUP INC (4.46M shares), T. Rowe Price Investment Management, Inc. (4M shares), DIMENSIONAL FUND ADVISORS LP (2.58M shares), ARMISTICE CAPITAL, LLC (2.04M shares), STATE STREET CORP (1.92M shares), BROWN ADVISORY INC (1.81M shares), Paradice Investment Management LLC (1.26M shares), ExodusPoint Capital Management, LP (1.25M shares), and D. E. Shaw & Co., Inc. (1.19M shares).
This table shows the top 280 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.